Munich, Germany

Rainer Jordan


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rainer Jordan: Innovator in Polyoxazoline Derivatives

Introduction

Rainer Jordan, an inventive mind based in Munich, Germany, has made significant strides in the field of polymer chemistry. His innovative work revolves around the development of polyoxazolines with unique functional properties that have potential applications in various scientific domains.

Latest Patents

Rainer holds a patent titled "Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds." This invention details the creation of novel functional polyoxazoline derivatives through the termination of polyoxazoline polymerization with inert chemical groups. Additionally, it encompasses the synthesis of innovative electrophilic initiators, which can survive polymerization conditions while retaining protected functional groups. These initiators facilitate the production of inert-terminal polyoxazoline derivatives and other related compounds. Furthermore, this patent discusses the creation of polyoxazoline-lipid conjugates and liposomal compositions derived from these conjugates, offering methods for preparing conjugates with target molecules.

Career Highlights

Rainer is currently associated with Serina Therapeutics, Inc., where his expertise in polymer chemistry significantly contributes to the company's research initiatives. His innovative approach and scientific knowledge have positioned him as a valuable asset in the advancement of new therapeutic technologies.

Collaborations

Rainer has collaborated with esteemed colleagues, including Michael David Bentley and J Milton Harris. Their combined efforts in research and development underscore the importance of teamwork in fostering innovation within the scientific community.

Conclusion

Rainer Jordan exemplifies the spirit of innovation through his patent contributions in the field of polyoxazolines. His work not only enhances the understanding of polymer chemistry but also holds promise for future applications in medical and pharmaceutical science. As he continues his endeavors at Serina Therapeutics, Rainer's creativity and dedication to research remain instrumental in shaping the future of this field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…